Drug Eluting Balloon Market, By Product Type (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon, Others), By Technology (FreePac, TransPac, EnduraCoa, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI2459

Pages :168

Formats :

Excel and PDF

Industry : Medical Devices

Drug Eluting Balloon Market Size and Trends

Global drug eluting balloon market is estimated to be valued at USD 776.8 Mn in 2025 and is expected to reach USD 1,402.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Drug Eluting Balloon Market Key Factors

To learn more about this report, Request sample copy

Global drug eluting balloon market has witnessed significant growth, owing to rising prevalence of cardiovascular diseases worldwide. As per estimates, cardiovascular diseases account for over 17.9 million deaths globally every year. Factors such as growing geriatric population, increasing obesity rates, and changing lifestyle habits increases the risk of cardiovascular diseases, and this boosts demand for drug eluting balloons as a safer minimally invasive treatment alternative to stenting. Ongoing advancements in balloon material and drug coating technologies drives the market growth by introducing newer and more effective products with enhanced vessel healing, antiesthetic, and anti-proliferative properties.

Market Driver – Increasing Product Launches by Key Market Players

Market players are engaged in launching new drugs, and this is expected to drive growth of the global drug eluting balloon market over the forecast period. For instance, in July 2021, Med Alliance SA, a medical technology company, launched ORIGIN SC and ORIGIN NC, two high performance drug eluting balloons for vessel preparation. These complement SELUTION SLR, its novel sirolimus-eluting balloon. ORIGIN SC is a semi-compliant (SC) PTCA balloon with a very low crossing profile, thus, making it an excellent choice for challenging lesions. ORIGIN SC offers one of the broadest portfolios of sizes available for an semi-compliant (SC) balloon, including 1.00 mm, 1.25 mm, 1.50 mm and 1.75 mm balloon diameters to treat very small vessels and complex cases. ORIGIN NC is a non-compliant (NC) PTCA balloon, combining high pressure tolerance and controlled compliance with an optimal crossing profile for the most challenging cases.